Health Care & Life Sciences » Pharmaceuticals | Whanin Pharmaceutical Co. Ltd.

Whanin Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
104,480
120,713
145,397
141,376
147,953
154,664
Cost of Goods Sold (COGS) incl. D&A
47,185
55,192
73,084
65,575
69,441
76,009
Gross Income
57,295
65,522
72,313
75,801
78,513
78,655
SG&A Expense
36,438
40,662
45,986
53,335
48,009
50,373
EBIT
20,149
24,005
25,412
21,625
29,651
27,343
Unusual Expense
736
925
586
1,440
1,256
428
Non Operating Income/Expense
99
1,328
190
265
5,971
548
Pretax Income
21,431
24,197
26,619
21,789
36,472
29,323
Income Tax
6,851
5,391
6,109
5,392
9,299
7,805
Consolidated Net Income
14,580
18,806
20,510
16,397
27,172
21,518
Net Income
14,580
18,806
20,510
16,397
27,172
21,518
Net Income After Extraordinaries
14,580
18,806
20,510
16,397
27,172
21,518
Net Income Available to Common
14,580
18,806
20,510
16,397
27,172
21,518
EPS (Basic)
955.00
1,232.00
1,343.00
1,074.00
1,780.00
1,409.44
Basic Shares Outstanding
15
15
15
15
15
15
EPS (Diluted)
955.01
1,231.77
1,343.39
1,074.04
1,779.80
1,409.44
Diluted Shares Outstanding
15
15
15
15
15
15
EBITDA
21,865
25,896
27,329
23,646
32,017
30,002
Other Operating Expense
707
854
916
841
853
940
Non-Operating Interest Income
2,116
2,445
1,983
1,869
2,105
2,100

About Whanin Pharmaceutical Co.

View Profile
Address
Whanin Building
Seoul SL 05809
Korea, Republic Of
Employees -
Website http://www.whanin.com
Updated 07/08/2019
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Lee Kwang-Sik in June 1978 is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.